How 433 Investors Unlocked 400X Return Potential

VCs back startups for outsized gains. Regular investors wait. But rule changes fixed that. Take Revolut. In 2016, 433 people averaged a $2,370 stake. Today? It's worth $1M+, up 89,900%. No wonder 10K+ people and the VCs behind Uber and eBay took the chance on Pacaso's $1.3T market disruption.

RARE
Ultragenyx Pharmaceutical Inc
NASDAQ
29.96
Open 30.27 Prev Close 30.30
High 30.60 Low 29.71
Volume 1,340,078 Volume (Avg) 1,914
52 Week High 60.37 52 Week Low 25.81
Market Cap 2.9B PE Ratio

Shares Stats

Shares Outstanding96,180,000
Shares Float89,640,000
Shares Short8,410,000
Insider Holdings314%
Institution Holdings101.52%

About Ultragenyx Pharmaceutical Inc

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme replacement therapy for the treatment of children and adults with Mucopolysaccharidosis VII; Dojolvi for the treatment of long-chain fatty acid oxidation disorders; and Evkeeza (evinacumab) for the treatment of homozygous familial hypercholesterolemia. The company's products candidates that are in Phase 3 clinical trials include UX143, a human monoclonal antibody for the treatment of osteogenesis imperfecta; UX111, an AAV9 gene therapy product candidate for the treatment of patients with Sanfilippo syndrome type A, or MPS IIIA, a rare lysosomal storage disease; DTX401, an adeno-associated virus 8 (AAV8) gene therapy clinical candidate for the treatment of patients with glycogen storage disease type Ia; DTX301, an AAV8 gene therapy for the treatment of patients with ornithine transcarbamylase; and GTX-102, an antisense oligonucleotide for the treatment of Angelman syndrome. It also develops UX701 that is in Phase 2 clinical trial for the treatment of Wilson disease; and UX053 for the treatment of glycogen storage disease type III. Ultragenyx Pharmaceutical Inc. has collaboration and license agreement with Kyowa Kirin Co., Ltd.; Saint Louis University; Baylor Research Institute; REGENXBIO Inc.; GeneTx; Mereo; University of Pennsylvania; Solid Biosciences Inc.; Regeneron; Abeona; and Arcturus Therapeutics Holdings Inc. The company was incorporated in 2010 and is headquartered in Novato, California.

General

NameUltragenyx Pharmaceutical Inc
TickerRARE
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees1,294

Highlights

Analyst Target86.05
Market Cap2,887,300,000
PEG Ratio-0.24
EBITDA-469,647,008

Financials

Curr Year EPS Estimate-5.06
Next Quarter EPS Estimate-1.31
Profit Margin-87.34%
Operating Margin-82.78
Return on Assets-0.22
Return on Equity-1.80
Revenue610.2M
Earnings Per Share-5.48
Revenue Per Share6.32
Gross Profit-167,803,008
Quarterly Revenue Growth0.13

Valuation

Price/Sales (Trailing 12 Mt.)4.73
Price/Book (Most Recent Quarter)19.09

Earnings

Most Popular

IRS Reportedly Confirms $1,390 Stimulus Checks For Eligible Americans, Rumors of $2,000 August Payout Debunked — Plans Late Summer Rollout (UPDATED)

Millions of Americans may be eligible for a $1,390 stimulus check by the U.S. Department of the Treasury and the Internal Revenue Service, as part of a plan aiming to provide financial relief to low and middle-income households.

Trump Exec Order to Help Restore Wealth for American Citizens? - Ad

Thanks to President Trump's Executive Order 14179, a brief "AI Wealth Window" is opening now. Genius investor James Altucher has released 3 AI wealth-building strategies to take advantage of Trump's genius Executive Order 14179. James believes you could see $10,000 grow to $1 MILLION or more over the next few years.

Kevin O'Leary Recalls How Cutting Off His Son's Trust Fund Drove Him To Harvard: 'The Dead Bird Under The Nest Never Learns To Fly'

Kevin O'Leary revealed that cutting off his son's trust fund after high school and insisting on self-reliance motivated him to earn a spot at Harvard, emphasizing that entitlement ruins ambition.

AeroVironment Set For Growth As Drones Take Center Stage In Defense

Needham analyst initiates AeroVironment at Buy with a $300 target, citing drone market growth, BlueHalo deal and rising defense share.

Will Your Savings Survive the August 31st Debt Ceiling Crisis? - Ad

On Aug 31, the U.S. runs out of "extraordinary measures" to avoid default. Insiders are moving into crisis-proof assets-while everyday Americans risk losing big. The FREE Mar-A-Lago Accord reveals where they're hiding wealth, how the Fed's response could crush the dollar, and 3 urgent moves to make now.

XRP Slips Below $3 But It Will Outperform ETH From Here, Trader Touts

XRP (CRYPTO: XRP) is expected to outperform Ethereum (CRYPTO: ETH) in the upcoming months, according to market commentators bullish on the token’s futur

Have You Seen this Strange Elon Musk Device? - Ad

Tech legend Jeff Brown predicts this "space technology" will be Elon Musk's next trillion-dollar business, and it will make a lot of people rich. This could be the biggest internet innovation since the first web browser Netscape kicked off the internet boom in the late 1990s.

An explosion at a plant owned by US Steel, an icon of American industry, has killed 2. What to know

An south of Pittsburgh killed two people and injured 10 others. The CEO has vowed to find out what caused Monday's blast while union officials say representatives will work to ensure a thorough investigation.

The US plans to build a $750M fly factory in Texas to stop a flesh-eating cattle parasite

The U.S. plans to build a $750 million factory in southern Texas to breed billions of sterile flies, ramping up its efforts to keep flesh-eating maggots in Mexico from crossing the border and damaging the American cattle industry.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

Cuban Has Resisted Presidential Run, but Says a Trump Third-Term Bid Could Draw Him Into the Race

Mark Cuban has resisted calls to run for president, but recently said that any effort by President Trump to seek a third term could drawn him into the race.

Peter Thiel-Backed Bullish Shoots Up 11% After-Hours Following Blockbuster IPO

Shares of cryptocurrency exchange Bullish soared over 11% in Wednesday's after-hours trading following the company's successful Wall Street debut.

What's inside Elon's building in Memphis will shock you - Ad

Inside Elon Musk's Memphis site lies a supercomputer built to power the world's first superhuman AI. It could make Elon a trillionaire - and new millionaires, too. With just $500, you could get in before the September 1st funding window closes.

Microsoft reviewing Israeli military's use of its tech amid worker protests

REDMOND, Wash. (AP) — Worker-led protests erupted at Microsoft headquarters this week as the tech company promises an “urgent” review of the Israeli military's use of its technology during the .

Elon's New Device Could Launch Biggest IPO of the Decade - Ad

Elon Musk's new device is being called a "game-changer"-and even the White House is using this tech. Jeff Brown says it could launch Musk's next trillion-dollar company and make early investors rich. You can claim a stake now for as little as $500.

Rivian's Affordable R2 May Unlock Massive Market Potential, Analyst Says

Rivian's upcoming R2 SUV is expected to drive growth for the company, with strong demand and a larger market reach projected by analyst Chris Pierce.

Warren Buffett Issues Cryptic Warning on U.S. Dollar - Ad

The world's wealthiest individuals are making huge moves with their money. Warren Buffett just liquidated billions of shares. Bill Gates sold 500,000 shares of Microsoft. Jeff Bezos filed to sell Amazon shares worth $4.8 billion. What is going on? One multi-millionaire believes they are preparing for a catastrophic event. But not a crash, bank run, or recession. It's something we haven't see in America for more than a century.

Intel Stock Is Trading Higher Tuesday: What's Going On?

Intel Corporation (NASDAQ:INTC) shares are trading higher Tuesday after CEO Lip-Bu Tan met with President Donald Trump in the White House on Monday.

India braces for export shock as US tariffs take effect

NEW DELHI (AP) — India is bracing for a sharp blow to its overseas trade as steep U.S. tariffs take effect on a range of Indian products Wednesday — a move that threatens over half of India’s exports to its largest market and highlights the fragile trade ties between the two countries.

October 16 Changes the Microchip Game - and Investing - Ad

George Gilder-dubbed "America's #1 Futurist"-says while everyone's chasing AI, the real opportunity is in a 4-nanometer tech millions of times more complex. It's not another chip - it replaces them. Now built in Arizona, Gilder says 3 companies tied to this "super-convergence" could soar.

Students face new cellphone restrictions in 17 states as school year begins

Jamel Bishop is seeing a big change in his classrooms as he begins his senior year at Doss High School in Louisville, Kentucky, where cellphones are now banned during instructional time.

Tesla Rival BYD Sets New Sales Record In India Amid Elon Musk-Led EV Giant's Push Into The Region

BYD's India sales hit record with 3,000 units sold in a week, facing challenges due to strained India-China ties as Tesla expands in India.

Crypto Genius: These 5 Altcoins Could Crush Bitcoin in 2025 - Ad

On August 30th, two powerful "Wealth Drivers" ignite what could be a 2025 super bull run-backed by Trump. The altcoin market as a whole has already soared 132,721% over the past ten years and could surge again. A $900 stake could turn into $108K over 12 months. This is The Great Gain of 2025.

Jensen Huang Hints At A 'New Brain' And A Monday Reveal: What's Nvidia Got In Store For This Robot?

Nvidia CEO Jensen Huang teased a robotics announcement framed as giving robots a "new brain," with details expected Aug. 25 after the company wrapped up a week celebrating 2 million developers and showcasing AI-powered robotics innovations.

Judge dismisses 2 counts against US Rep. Cuellar of Texas, moves bribery trial to next year

HOUSTON (AP) — A judge on Thursday granted a request by federal prosecutors to dismiss two of the 14 counts against U.S. Rep. of Texas and his wife, as part of a . The judge also ordered that their trial, which had been set for September, be rescheduled for next year.

How 433 Investors Unlocked 400X Return Potential - Ad

VCs back startups for outsized gains. Regular investors wait. But rule changes fixed that. Take Revolut. In 2016, 433 people averaged a $2,370 stake. Today? It's worth $1M+, up 89,900%. No wonder 10K+ people and the VCs behind Uber and eBay took the chance on Pacaso's $1.3T market disruption.

What's Going On With Coherent Stock On Thursday?

Coherent shares are trading lower on Thursday after the company announced it will sell its aerospace and defense unit for $400 million.

Trump Exec Order to Help Restore Wealth for American Citizens? - Ad

Thanks to President Trump's Executive Order 14179, a brief "AI Wealth Window" is opening now. Genius investor James Altucher has released 3 AI wealth-building strategies to take advantage of Trump's genius Executive Order 14179. James believes you could see $10,000 grow to $1 MILLION or more over the next few years.

Ukrainian drone attacks on oil refineries have some Russian regions running on empty

Gas stations have run dry in some regions of Russia after Ukrainian drones struck in recent weeks, with motorists waiting in long lines and officials resorting to rationing or cutting off sales altogether.

5 Regional Bank Stocks Exploding Higher

Regional banks MBCN, PVBC, UBCP, NKSH, and FVCB surge in quality rankings, signaling strong financial health. Explore opportunities.

Will Your Savings Survive the August 31st Debt Ceiling Crisis? - Ad

On Aug 31, the U.S. runs out of "extraordinary measures" to avoid default. Insiders are moving into crisis-proof assets-while everyday Americans risk losing big. The FREE Mar-A-Lago Accord reveals where they're hiding wealth, how the Fed's response could crush the dollar, and 3 urgent moves to make now.

Keurig Dr Pepper to buy Peet's Coffee owner in $18 billion deal

NEW YORK (AP) — Keurig Dr Pepper said Monday it will buy Peet's Coffee owner JDE Peet's in a deal worth about $18 billion (15.7 billion euro).

Epstein accuser Virginia Giuffre wrote a memoir. Months after her death, it's coming out

NEW YORK (AP) — A posthumous and “unsparing” memoir by one of most prominent accusers, will be published this fall, publishing house Alfred A. Knopf said Sunday.

Have You Seen this Strange Elon Musk Device? - Ad

Tech legend Jeff Brown predicts this "space technology" will be Elon Musk's next trillion-dollar business, and it will make a lot of people rich. This could be the biggest internet innovation since the first web browser Netscape kicked off the internet boom in the late 1990s.

Cathie Wood's Ark Dumps $1.6 Million In Robinhood Stock Amid AI Launch Hype, Dumps Shopify Stock As Well

Cathie Wood's Ark Invest traded millions worth of Shopify and Robinhood shares, while Shopify posted strong earnings and Robinhood launched AI tool.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service